Are you sure you'd like to remove this alert? You will no longer receive email updates about this topic.
Over the past year a number of medical device sterilization facilities that use ethylene oxide, or EtO, have shut down as state regulators have raised concerns about their potential environmental impact. On this week’s podcast, executive editor Shawn M. Schmitt chats with senior reporter Danny Al-Faruque about what’s happened to date, as well as where this EtO issue is headed in the future.
Device Week, 29 November 2019 – Top Clinical Trial News From AHA & Investment Forecast From Jefferies 2019
In this week's Medtech Insight podcast, deputy editor Reed Miller discusses clinical trial news from the annual American Heart Association (AHA) meeting, and senior reporter Catherine Longworth highlights goings-on at the Jefferies Healthcare Conference in London.
Enforcement of the False Claims Act is always a hot-button topic for industry. That’s because fines for FCA violations can be costly, reaching into the billions of dollars. On this week’s podcast, executive editor Shawn M. Schmitt chats with senior reporter Elizabeth Orr about some of the more important FCA cases from 2019.
Device Week, 14 November 2019 – Medtech Leaders Look To The Future At XMed 2019; Abbott Names New CEO
In this week's podcast, Medtech Insight managing editor Marion Webb summarizes her recent interviews with Ted Tanner, CTO of IBM Watson Health, and Catherine Mohr, president of the Intuitive Foundation, during the Exponential Medicine conference in San Diego. And deputy editor Reed Miller discusses the appointment of Robert Ford as the new CEO of Abbott Laboratories, the latest in a recent series of high-profile CEO appointments in medtech.
Some exciting changes to US Medicare payment rules will take effect in January for device-related procedures performed in different hospital settings. On this week’s podcast, executive editor Shawn M. Schmitt chats with senior reporter Sue Darcey, who covered these changes for Medtech Insight – as well news out of the Centers for Medicare and Medicaid Services (CMS) that it designated several new medical technologies for passthrough payments and will offer new home-use infusion therapy benefits.
In this week's podcast, Medtech Insight managing editor Marion Webb discusses the emergence of virtual assistants in health care and deputy editor Reed Miller reviews Edwards Lifesciences' third-quarter results.
In this edition of Device Week, Medtech Insight senior reporter Ferdous Al-Faruque chats with senior reporters Sue Darcey and Elizabeth Orr about changes to the Anti-Kickback Statutes and the Stark Law, and what that means for the medical device industry as well as the legal community.
Device Week, 17 October 2019 – A Mix Of Earnings and 'Taboo' Tech: Johnson & Johnson's Third-Quarter Earnings; Tech Innovations Around Sex And Death
In this edition of Device Week, Medtech Insight managing editor Marion Webb chats with deputy editor Reed Miller about the most recent earnings report from Johnson & Johnson, and talks with London-based Catherine Longworth about her upcoming "taboo" tech coverage from the 2019 Global Innovation and New Technology Health Event (GIANT).
On this week’s podcast, executive editor Shawn M. Schmitt and senior reporter Elizabeth Orr delve into recent news on medical device recalls, including tips and advice from US FDA officials, and a report about a new app that scans products and gives detailed safety and recall information.
In this week's podcast, senior reporter Catherine Longworth provides an update on how the Demant Group is recovering from a ransomware attack that forced the Danish hearing-aid manufacturer to shut down its IT systems, and deputy editor Reed Miller reviews the highlights of the clinical trial presentations at the recent Transcatheter Cardiovascular Therapeutics (TCT) conference in San Francisco.
All set! This article has been sent to email@example.com.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
Please Note: Only individuals with an active subscription will be able to access the full article. All other readers will be directed to the abstract and would need to subscribe.